The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Mr Singh...I am glad I could bring some levity to your day as the all caps posts could be a sign of a stressful day. Just speculating.
I am building a core position here and taking advantage of any weakness. If I was in this for a trade then would have traded the $12 spike Friday....as you did. Congratulations.
Sit back and enjoy your profits.
Double bottom is in
My ADS shares where in my account on Friday and fully tradable with my broker.
Fully funded in my book means you have enough cash to continue running for the foreseeable future. Not that we will be raising equity two days after saying we are fully funded.
I appreciate they will need cash and it is prudent to raise into the share price strength.
Just saying it looks to me their words said one thing Thursday and their actions another.
This also doesn’t seem to be off of the ATM facility as some have stated previously.
As aside after hours closed down 9.35% in US at $6.35 on volume of 126K.
Didn’t they say on the recent video that they were fully funded until 2021? Two trading days later raising money?
Given the share price strength not an out of this world thing to do but seems at odds with their statement last Thursday that fully funded?
They missed street forecast EPS and revenue. Still think the analyst community isn’t sold that Remdisivir despite being approved is a money maker for them.
Also think analysts are waking up to there is potentially more money in early stage therapeutics I.e stop patients getting hospitalized. From my understanding Remdisivir is a later stage treatment once people are hospitalized.
Things moving fast now as some Republican Senators are backing TT being sold to a US company.
Not sure what effect here if sold.
MSFT our talks on hold, for now, as POTUS expressed opposition to transaction.
High of $12.17 on Nasdaq
For illustration purposes only on ADR:
Holding prior to additional 1.5 shares issues - 1 share trading at $10 = $10 value
You then get 1.5 additional shares giving you 2.5 shares in total. Share price $10 divided by 2.5 shares gives a share price of $4.
All for illustration purposes only.
$12.45 bid $12.60 offer
Anyone have a good source of prices for the three issues they have? Cheers
Everyone excited for tonight’s webinar....oh they are going to announce something big.....
TILS pre-announce topics for the webinar and people sell.
What’s changed?
You don’t spin off a company without considering all implications e.g. valuation, tax etc. You could have any potential gains hit with unforeseen taxes if you don’t do your homework.
Nothing changed for me. Feel sorry for those whose stop losses got tripped hopefully they can get back in at a decent price.
Is there a link for this webinar? I must have missed it. Cheers
Jtara...this sounds like it is just a database issue at IA. Sometimes get that with my broker in US and they just add the company to their database.
Be careful with OTC as trades on a matched basis and nowhere as liquid.
Wouldn't be surprised to see Pfizer on the radar as possible investor .
"Pfizer plans to take non-controlling stakes in these companies and help usher their medicines forward."
https://www.biopharmadive.com/news/pfizer-business-head-details-new-500m-project-for-investing-in-public-biot/579139/
If Mount Sinai are aware of the trial that’s good news for me. They are a large health care / hospital group in the New York area and well connected.
Hopefully raising the profile of Synairgen in US.
I’d